Skip to main content
Clinical Trials/NCT05264558
NCT05264558
Completed
Phase 4

Preparing for the Final Phase of Hepatitis C Elimination in Cairns: An Implementation Trial of a Test and Treat Approach to Reach the Final 30%.

Macfarlane Burnet Institute for Medical Research and Public Health Ltd1 site in 1 country606 target enrollmentJuly 25, 2022

Overview

Phase
Phase 4
Intervention
Xpert HCV Viral load finger stick point of care test (Cepheid)
Conditions
Hepatitis C
Sponsor
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Enrollment
606
Locations
1
Primary Endpoint
HCV testing
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The study aims to assess the impact of models of HCV care on HCV testing, treatment uptake and cure within Cairns. Point of care testing for HCV , with test and treat strategies will be offered within a primary care service.

Detailed Description

Available testing and treatment data will be explored pre and post the intervention period of the project within Cairns Hinterland health services that provide hepatitis C care. Test and treat strategies of the project will include: Part A: Same day test and treat clinical trial. The study will explore a 'same day test and treat' model to determine the impact on HCV treatment initiation and cure within a primary care service that recognises that they see people at risk of hepatitis C that are transient, and struggle to return to a care provider to engage in hepatitis C testing and care. 1. HCV RNA point of care (POC) testing 2. Epclusa (Sofosbuvir/Velpatasvir 400mg/100mg) course initiated at same day of visit following a +ve HCV RNA result from the POC test. Part B: Refresher and clinic in reach support work Primary care service/ General practitioner education and training \~1 hour in-person training for all clinic staff on hepatitis C testing, treatment, retention in HCV care cascade. Part C: Services evaluation with incentive and peer intervention in HCV care cascade.

Registry
clinicaltrials.gov
Start Date
July 25, 2022
End Date
September 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • attending primary health care service of CHHS aged 18 years or over

Exclusion Criteria

  • only for intervention arm test and treat
  • Known to have hepatitis B or HIV infection
  • Known to have cirrhosis
  • Previous treatment with direct acting antivirals
  • Previously received interferon-based hepatitis C treatment that did not work
  • Women that are pregnant or breastfeeding
  • Already receiving hepatitis C treatment.

Arms & Interventions

Test and treat

This group will receive POC HCV viral load testing via a fingerstick using the Xpert HCV Viral load finger stick point of care test (Cepheid) in addition to the standard of care whole blood conventional laboratory based HCV PCR viral load testing. Participants who return a positive POC HCV viral load result will be provided with Epclusa on the same day as result. Follow up management will be determined by results received from standard of care blood. Service level data will be investigated to estimate HCV targeted treatment numbers prior to intervention arms implementation. Service level data will be measured post intervention periods.

Intervention: Xpert HCV Viral load finger stick point of care test (Cepheid)

Test and treat

This group will receive POC HCV viral load testing via a fingerstick using the Xpert HCV Viral load finger stick point of care test (Cepheid) in addition to the standard of care whole blood conventional laboratory based HCV PCR viral load testing. Participants who return a positive POC HCV viral load result will be provided with Epclusa on the same day as result. Follow up management will be determined by results received from standard of care blood. Service level data will be investigated to estimate HCV targeted treatment numbers prior to intervention arms implementation. Service level data will be measured post intervention periods.

Intervention: Epclusa 400Mg-100Mg Tablet

General Practitioner Refresher and Clinic in reach

Perform hepatitis C education for GP and clinic staff at primary health services; on hepatitis testing and treatment at a service level will offer the opportunity to tailor education to the requirements of the clinic and staffing needs.Service level data will be investigated to estimate HCV targeted treatment numbers prior to intervention arms implementation. Service level data will be measured post intervention period

Intervention: Standard of care

Incentive and Peer intervention in HCV care cascade

Assess the effectiveness in primary health services of engaging people in hepatitis C testing, and retention throughout the care cascade whilst employing innovative techniques including incentives and peer recruitment.Service level data will be investigated to estimate HCV targeted treatment numbers prior to intervention arms implementation. Service level data will be measured post intervention period

Intervention: Standard of care

Outcomes

Primary Outcomes

HCV testing

Time Frame: 12 months

The number of participants who receive HCV testing in each of the arms

HCV treatment

Time Frame: 12 months

The number of participants who start HCV treatment in each of the arms

Study Sites (1)

Loading locations...

Similar Trials